Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.

Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X; IMAGE Study Group.

Arthritis Rheumatol. 2014 Jun;66(6):1672-7. doi: 10.1002/art.38389.

2.

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ.

Kidney Int. 1998 Mar;53(3):743-53.

3.

Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).

Wang G, Csernok E, de Groot K, Gross WL.

J Immunol Methods. 1997 Oct 27;208(2):203-11.

PMID:
9433475
4.
5.

Antigenic specificity of anti-neutrophil cytoplasmic antibody.

Fu HL, Hsu TC, Chang CC, Tsay GJ.

J Formos Med Assoc. 2001 Jan;100(1):35-9.

PMID:
11265258
6.
7.

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.

Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL.

Ann Intern Med. 1997 Jun 1;126(11):866-73.

PMID:
9163287
8.

A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M.

J Clin Pathol. 1998 Aug;51(8):568-75.

9.

Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.

Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C.

Arthritis Rheum. 2005 Sep;52(9):2926-35.

10.

Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review.

Ying CM, Yao DT, Ding HH, Yang CD.

PLoS One. 2014 Feb 25;9(2):e89777. doi: 10.1371/journal.pone.0089777. eCollection 2014. Review.

12.

Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.

Molnár K, Kovács L, Kiss M, Husz S, Dobozy A, Pokorny G.

Clin Exp Dermatol. 2002 Jan;27(1):59-61.

PMID:
11952673
15.

Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.

Schönermarck U, Lamprecht P, Csernok E, Gross WL.

Rheumatology (Oxford). 2001 Feb;40(2):178-84.

PMID:
11257154
16.

Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine.

Choi HK, Slot MC, Pan G, Weissbach CA, Niles JL, Merkel PA.

Arthritis Rheum. 2000 Nov;43(11):2488-92.

17.

Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.

Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA.

Arthritis Rheum. 2000 Jan;43(1):226-31. Review.

18.

Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance.

Font J, Ramos-Casals M, Cervera R, Bosch X, Mirapeix E, García-Carrasco M, Morlà RM, Ingelmo M.

Br J Rheumatol. 1998 Dec;37(12):1287-91.

PMID:
9973150
20.

Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.

Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M, Grypiotis P, Todesco S.

J Rheumatol. 2002 May;29(5):918-23.

PMID:
12022350

Supplemental Content

Support Center